Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Marquès MA"'
Autor:
Duparc T; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France., Gore E; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France., Combes G; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France.; Institut Hospitalo-Universitaire HealthAge, (IHU HealthAge), INSERM, Toulouse University Hospital, Toulouse, France., Beuzelin D; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France.; Lifesearch SAS, Toulouse, France., Pires Da Silva J; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France., Bouguetoch V; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France.; Institut Hospitalo-Universitaire HealthAge, (IHU HealthAge), INSERM, Toulouse University Hospital, Toulouse, France.; Lifesearch SAS, Toulouse, France., Marquès MA; MetaDiab, I2MC, University of Toulouse, INSERM, UPS, UMR1297, Toulouse, France., Velazquez A; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France., Viguerie N; MetaDiab, I2MC, University of Toulouse, INSERM, UPS, UMR1297, Toulouse, France., Tavernier G; MetaDiab, I2MC, University of Toulouse, INSERM, UPS, UMR1297, Toulouse, France., Arner P; Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden., Rydén M; Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden., Langin D; Institut Hospitalo-Universitaire HealthAge, (IHU HealthAge), INSERM, Toulouse University Hospital, Toulouse, France.; MetaDiab, I2MC, University of Toulouse, INSERM, UPS, UMR1297, Toulouse, France.; Biochemistry Laboratory, Toulouse University Hospital, Toulouse, France.; Institut Universitaire de France (IUF), Paris, France., Sioufi N; Institut Hospitalo-Universitaire HealthAge, (IHU HealthAge), INSERM, Toulouse University Hospital, Toulouse, France.; Lifesearch SAS, Toulouse, France., Nasser M; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France.; Institut Hospitalo-Universitaire HealthAge, (IHU HealthAge), INSERM, Toulouse University Hospital, Toulouse, France., Cabou C; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France.; Institut Hospitalo-Universitaire HealthAge, (IHU HealthAge), INSERM, Toulouse University Hospital, Toulouse, France., Najib S; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France.; Institut Hospitalo-Universitaire HealthAge, (IHU HealthAge), INSERM, Toulouse University Hospital, Toulouse, France., Martinez LO; LiMitAging, Institute of Metabolic and Cardiovascular Diseases (I2MC), University of Toulouse, INSERM, Université Toulouse III - Paul Sabatier (UPS), UMR1297, Toulouse, France.; Institut Hospitalo-Universitaire HealthAge, (IHU HealthAge), INSERM, Toulouse University Hospital, Toulouse, France.
Publikováno v:
JCI insight [JCI Insight] 2024 Mar 12; Vol. 9 (8). Date of Electronic Publication: 2024 Mar 12.
Autor:
Vion J; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Sramkova V; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.; Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France., Montastier E; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France.; Departments of Nutrition and Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France., Marquès MA; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France., Caspar-Bauguil S; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France.; Departments of Nutrition and Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France., Duparc T; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Martinez LO; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Bourlier V; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Harant I; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Larrouy D; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Moussaoui N; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Bonnel S; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Vindis C; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Clinical Investigation Center, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Toulouse University Hospitals, CIC1436, F-CRIN/FORCE Network, Toulouse, France., Dray C; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Valet P; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Saulnier-Blache JS; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Schanstra JP; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France., Thalamas C; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Clinical Investigation Center, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Toulouse University Hospitals, CIC1436, F-CRIN/FORCE Network, Toulouse, France., Viguerie N; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Departments of Nutrition and Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France., Moro C; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France., Langin D; Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France.; Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France.; Departments of Nutrition and Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France.; Institut Universitaire de France, IUF, Paris, France.
Publikováno v:
American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2021 Sep 01; Vol. 321 (3), pp. E325-E337. Date of Electronic Publication: 2021 Jul 12.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.